Home    Back

Suramin    (DrugBank: Suramin)

1 disease
IDDisease name (Link within this page)Number of trials
331Idiopathic multicentric castleman disease1

331. Idiopathic multicentric castleman disease    [ 30 clinical trials,   44 drugs,   (DrugBank: 23 drugs),   30 drug target genes,   148 drug target pathways]
Searched query = "Idiopathic multicentric castleman disease", "Castleman disease"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 30 trial found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT00002652
(ClinicalTrials.gov)		May 19951/11/1999Suramin in Treating Patients With Refractory or Relapsed Multiple Myeloma or Castleman's DiseaseA PHASE II PILOT STUDY OF SURAMIN IN PREVIOUSLY TREATED PATIENTS WITH MULTIPLE MYELOMA AND PATIENTS WITH CASTLEMAN'S DISEASEMultiple Myeloma and Plasma Cell NeoplasmDrug: suraminUniversity of ArkansasNational Cancer Institute (NCI)Completed18 YearsN/ABothPhase 2United States